US_FEDERAL process · buyer country US · award
PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.
Department of Health and Human Services
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
- Buyer identifier
- Not reported
- Primary supplier
- CREATIVE BIOLABS INC
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- Not reported
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.
Suppliers
- CREATIVE BIOLABS INC · primary
Official lifecycle
Process timeline
- Award announced
PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.
- Value increased
PURCHASE ORDER FOR 10 MG EACH OF ANTI-GD2-ANTIBODY-IL21 AND IL 15 FUSION PROTEINS.
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|